(3S,7E,9R)-3,9-Dihydroxy-5,7-megastigmadiene

Details

Top
Internal ID 2dab7150-9f81-44ff-9dd5-ea402d653444
Taxonomy Lipids and lipid-like molecules > Prenol lipids > Sesquiterpenoids
IUPAC Name (1S,4R)-4-[(E,3R)-3-hydroxybut-1-enyl]-3,5,5-trimethylcyclohex-2-en-1-ol
SMILES (Canonical) CC1=CC(CC(C1C=CC(C)O)(C)C)O
SMILES (Isomeric) CC1=C[C@H](CC([C@H]1/C=C/[C@@H](C)O)(C)C)O
InChI InChI=1S/C13H22O2/c1-9-7-11(15)8-13(3,4)12(9)6-5-10(2)14/h5-7,10-12,14-15H,8H2,1-4H3/b6-5+/t10-,11-,12+/m1/s1
InChI Key YTPJSSUCMUKHHN-QEPQOOGFSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C13H22O2
Molecular Weight 210.31 g/mol
Exact Mass 210.161979940 g/mol
Topological Polar Surface Area (TPSA) 40.50 Ų
XlogP 1.70
Atomic LogP (AlogP) 2.28
H-Bond Acceptor 2
H-Bond Donor 2
Rotatable Bonds 2

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (3S,7E,9R)-3,9-Dihydroxy-5,7-megastigmadiene

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9939 99.39%
Caco-2 + 0.6901 69.01%
Blood Brain Barrier + 0.5500 55.00%
Human oral bioavailability - 0.6000 60.00%
Subcellular localzation Mitochondria 0.5543 55.43%
OATP2B1 inhibitior - 0.8599 85.99%
OATP1B1 inhibitior + 0.9067 90.67%
OATP1B3 inhibitior + 0.9686 96.86%
MATE1 inhibitior - 1.0000 100.00%
OCT2 inhibitior - 0.9000 90.00%
BSEP inhibitior - 0.9279 92.79%
P-glycoprotein inhibitior - 0.9628 96.28%
P-glycoprotein substrate - 0.8845 88.45%
CYP3A4 substrate - 0.5303 53.03%
CYP2C9 substrate - 0.8001 80.01%
CYP2D6 substrate - 0.7466 74.66%
CYP3A4 inhibition - 0.8172 81.72%
CYP2C9 inhibition - 0.8592 85.92%
CYP2C19 inhibition - 0.7282 72.82%
CYP2D6 inhibition - 0.9360 93.60%
CYP1A2 inhibition - 0.8643 86.43%
CYP2C8 inhibition - 0.9401 94.01%
CYP inhibitory promiscuity - 0.7550 75.50%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.6765 67.65%
Carcinogenicity (trinary) Non-required 0.5508 55.08%
Eye corrosion - 0.9311 93.11%
Eye irritation - 0.7409 74.09%
Skin irritation + 0.5118 51.18%
Skin corrosion - 0.9164 91.64%
Ames mutagenesis - 0.7900 79.00%
Human Ether-a-go-go-Related Gene inhibition - 0.6932 69.32%
Micronuclear - 0.8800 88.00%
Hepatotoxicity - 0.6625 66.25%
skin sensitisation + 0.9246 92.46%
Respiratory toxicity - 0.5000 50.00%
Reproductive toxicity - 0.5667 56.67%
Mitochondrial toxicity - 0.7125 71.25%
Nephrotoxicity - 0.7161 71.61%
Acute Oral Toxicity (c) III 0.8456 84.56%
Estrogen receptor binding - 0.8927 89.27%
Androgen receptor binding - 0.7417 74.17%
Thyroid receptor binding - 0.6077 60.77%
Glucocorticoid receptor binding - 0.6805 68.05%
Aromatase binding - 0.8960 89.60%
PPAR gamma - 0.8376 83.76%
Honey bee toxicity - 0.8800 88.00%
Biodegradation - 0.7000 70.00%
Crustacea aquatic toxicity - 0.6200 62.00%
Fish aquatic toxicity + 0.7552 75.52%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 93.75% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 92.35% 91.11%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 88.66% 85.14%
CHEMBL253 P34972 Cannabinoid CB2 receptor 85.56% 97.25%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 85.30% 95.56%
CHEMBL2581 P07339 Cathepsin D 83.71% 98.95%
CHEMBL3359 P21462 Formyl peptide receptor 1 82.93% 93.56%
CHEMBL221 P23219 Cyclooxygenase-1 82.70% 90.17%
CHEMBL3492 P49721 Proteasome Macropain subunit 81.16% 90.24%
CHEMBL3137262 O60341 LSD1/CoREST complex 81.08% 97.09%
CHEMBL1937 Q92769 Histone deacetylase 2 80.35% 94.75%

Cross-Links

Top
PubChem 101338767
NPASS NPC70691
LOTUS LTS0225689
wikiData Q105361819